Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings.

@article{Bubendorf2001MultiprobeFF,
  title={Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings.},
  author={Lukas Bubendorf and Bruno Grilli and Guido Sauter and Michael J. Mihatsch and T. Christian Gasser and Peter Dalquen},
  journal={American journal of clinical pathology},
  year={2001},
  volume={116 1},
  pages={
          79-86
        }
}
The aim of this study was to evaluate the UroVysion (Vysis, Downers Grove, IL) fluorescence in situ hybridization (FISH) test for improved detection of bladder cancer in urinary specimens. Three groups of specimens were examined, including voided urine specimens (1) collected before resection of bladder cancer, (2) from cystoscopically negative bladders of patients with previous bladder cancer, and (3) from patients with benign prostatic hyperplasia (controls). FISH positivity was defined as… Expand
The Utility of Fluorescence In Situ Hybridization for Detection of Bladder Urothelial Carcinoma in Routine Clinical Practice
TLDR
The sensitivity of FISH for detecting BUC was superior to that of cytology, regardless of tumor stage and grade, and FISH is a significant additional and complementary method for detection of BUC in patients who have suspicious lesions on cystoscopy. Expand
Multicolor fluorescence in situ hybridization (M-FISH) on cells from urine for the detection of bladder cancer
TLDR
Sensation of FISH on cells from urine has been shown in all studies to be highly sensitive and specific for detection of bladder cancer and can be used in routine diagnosis additionally to conventional cytology especially in doubtful or negative cases. Expand
Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology.
TLDR
FISH improves the sensitivity rates obtained with urine cytology for bladder cancer detection in all tumor grades and stages, and offers similar specificity, and doubles the accuracy of urinary cytology in application to low grade-stage tumors, and detects all high grade infiltrating tumors. Expand
Clinical Utility of Fluorescence in Situ Hybridization for Voided Urine for the Diagnosis and Surveillance of Bladder Cancer
TLDR
The findings show that the sensitivity of FISH for voided urine samples is higher than that of cytology, but the specificity was not significantly different. Expand
Bladder Cancer Detection Using FISH (UroVysion Assay)
TLDR
The UroVysion assay works by detecting urinary cells that have chromosomal abnormalities consistent with a diagnosis of bladder cancer, and may be useful for assessing superficial bladder cancer patients' response to bacillus Calmette-Guerin therapy and in detecting upper tract urothelial carcinoma. Expand
FISH Assay for THE Detection of Bladder Cancer
TLDR
The sensitivity and specificity of fluorescence in situ hybridization performed on the urine specimens of patients under follow-up for superficial bladder cancer and the FISH assay in detecting non-invasive urothelial tumors is worth further studies. Expand
Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings.
TLDR
A proportion of patients under surveillance for recurrent bladder carcinoma with no immediate evidence of bladder tumor recurrence have positive multitarget fluorescence in situ hybridization (FISH) results, defining the anticipatory positive subset. Expand
Comparison of the Efficacy of Urine Cytology, Nuclear Matrix Protein 22(NMP22), and Fluorescence in Situ Hybridization(FISH) for the Diagnosis of Bladder Cancer
TLDR
FISH is more sensitive in low-grade bladder cancer than is urine cytology and can be used as a diagnostic tool for the detection of primary and recurrent bladder cancer. Expand
Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
TLDR
The UroVysion FISH assay provides high sensitivity and specificity to detect transitional cell carcinoma in cytologically equivocal and negative urine samples, and emphasize the important role of this assay in the management of bladder cancer. Expand
Multi‐target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer
TLDR
Multi‐target FISH may help to stratify the risk of recurrence of UC at the time of a negative follow‐up cystoscopy, and the sensitivity of the FISH test to predict recurrence was significantly improved by considering specimens with rare tetraploids as negative. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 34 REFERENCES
Interphase cytogenetic diagnosis of bladder cancer on cells from urine and bladder washing.
TLDR
FISH on cells from urine samples is an effective complement to the standard urine cytology and characterized by high specificity and sensitivity in tumors with T-category higher than pTa and grade higher than G1. Expand
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.
TLDR
The sensitivity of FISH for the detection of urothelial carcinoma is superior to that of cytology, and the specificity of Fish and cytology for uroclinical carcinoma are not significantly different. Expand
Chromosomal Numerical Aberrations Detected by Fluorescence in situ Hybridization on Bladder Washings from Patients with Bladder Cancer
TLDR
Although better hybridization efficiency was obtained on touch biopsy slides, the results in bladder washings were in high concordance and FISH analysis on bladder washing samples may become a simple tool to improve the accuracy of cytology. Expand
Immunocyt: a new tool for detecting transitional cell cancer of the urinary tract.
TLDR
Investigating the diagnostic value of the newly developed immunocytochemical test, Immunocyt, which detects cellular markers specific for transitional cell cancer in the voided urine of patients with bladder cancer found it to be a noninvasive, highly sensitive test for detecting transitional cell carcinoma of all grades and stages. Expand
A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors.
TLDR
The results obtained show that the FISH technique, particularly when used on urine, is a very useful tool in the diagnosis, early detection, and management of bladder cancer. Expand
Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer: experience with 130 patients with biopsy confirmed tumor.
TLDR
NMP22 has sensitivity and specificity similar to those of cytology from bladder washout samples, but cannot replace cystoscopy in clinical practice, as the danger of missing NMP22 negative tumors is too high to rely on its results in an individual patient. Expand
Chromosome 9 monosomy by fluorescence in situ hybridization of bladder irrigation specimens is predictive of tumor recurrence.
TLDR
The hypothesis that losses of tumor suppressor genes on chromosome 9 are critical, perhaps initiating genetic events in bladder cancer is supported. Expand
Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma.
TLDR
Microdissection of urothelial lesions, obtained during AFE, has led to the first unequivocal documentation of genetic changes in uroselial lesions diagnosed as normal in histopathology. Expand
The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.
TLDR
It is demonstrated that a multitarget, multicolor FISH assay containing centromeric probes to chromosomes 3, 7, and 17 and a locus-specific probe to band 9p21 has high sensitivity and specificity for the detection of UC in voided urine specimens. Expand
The clinical value of urinary cytology: 12 years of experience with 615 patients.
TLDR
Cytology in bladder washings provides considerably more information that exfoliative cytology, stressing the need for additional diagnostic tests such as staining with monoclonal antibodies directed against tumour antigens or assessment of ploidy. Expand
...
1
2
3
4
...